{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-24-000738","form_type":"8-K","ticker":"LCTC","cik":"0001493137","company_name":"Lifeloc Technologies, Inc","filed_at":"2024-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.646306+00:00","generated_at":"2026-06-01T22:56:57.663009+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.72,"calibrated_materiality_score":0.72,"confidence":"high","headline":"Lifeloc Q1 net loss widens to $284K; revenue flat at $2.15M","bullets":["Net revenue $2.153M flat YoY ($2.165M); net loss $(284)K ($0.12/diluted) vs $(54)K loss ($0.02/sh).","Gross margin declined to 38.8% from 43.2% due to inflation-driven cost increases.","R&D spending rose 40% primarily for SpinDx drug testing platform development.","Beta testing of SpinDx saliva THC detection expected later in 2024; commercial launch projected 2025.","Smartphone pairing for LX9 breathalyzer expected in Q2 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-24-000738","json":"https://secwatch.observer/filing/0001079973-24-000738.json","markdown":"https://secwatch.observer/filing/0001079973-24-000738.md","text":"https://secwatch.observer/filing/0001079973-24-000738.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1493137/000107997324000738/0001079973-24-000738-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1493137/000107997324000738/lclc_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T22:56:57.663009+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"93a371465c7fb06a562d1667b83fdd4fd6ebf7d4","claim":"Lifeloc Technologies, Inc reported first quarter ended March 31, 2024 results: revenue $2.153 million, net income $(284) thousand, EPS $(0.12) per diluted share.","evidence_excerpt":"Lifeloc posted quarterly net revenue of $2.153 million resulting in a quarterly net loss of $(284) thousand, or $(0.12) per diluted share.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1493137/000107997324000738/0001079973-24-000738-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$2.153 million"},{"label":"Net income","value":"$(284) thousand"},{"label":"EPS","value":"$(0.12) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}